Fetuins are members of the cystatin superfamily of cysteine protease inhibitors (1-3). Additional members of this superfamily are kininogen and histidine-rich glycoprotein. Fetuin A and B are two known members of the fetuin family. Hepatocytes are believed to be the principal cellular source, but other cell types also express it (4, 5). Fetuin A, also known as alpha 2-Heremans-Schmid glycoprotein, is an inhibitor of basic calcium phosphate precipitation and a negative acute-phase protein (6, 7). Normal circulating levels of Fetuin A in adults (300-600 μg/mL) fall significantly (30-50%) during injury and infection (7). Fetuin B is a newer member whose function is not fully characterized (1, 2). Fetuin A and B display similarities and differences in their characteristics. Fetuin B exhibits reduction of calcification, while both mRNA levels were down‑regulated during the acute phase in inflammation-induced rats (4). However, they share only 20% amino acid sequence identity (2). The amounts of Fetuin B in human serum, unlike Fetuin A, vary with gender and are higher in females than in males (4).
Recombinant Human Fetuin B Protein, CF
R&D Systems | Catalog # 1725-PI
Loading...
Key Product Details
- R&D Systems NS0-derived Recombinant Human Fetuin B Protein (1725-PI)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
NS0
Accession Number
Applications
Inhibition Activity
Loading...
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human Fetuin B protein
Met19-Pro382, with a C-terminal 10-His tag
Met19-Pro382, with a C-terminal 10-His tag
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Met19
Predicted Molecular Mass
42 kDa
SDS-PAGE
54 kDa and 58 kDa, reducing conditions
Activity
Measured by its ability to inhibit active Cathepsin V cleavage of a fluorogenic peptide substrate Z-LR-AMC (Catalog # ES008).
The IC50 value is <150 nM, as measured under the described conditions.
Formulation, Preparation, and Storage
1725-PI
| Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Fetuin B
References
- Oliver, E., et al. (1999) Genomics. 57:352.
- Oliver, E., et al. (2000) Biochem. J. 350:589.
- Kellemann, J. et al., 1989, J. Biol. Chem. 264:14121.
- Denecke, B. et al. (2003) Biochem. J. 376:135.
- Schäfer, C., et al. (2003) J. Clin. Invest. 112:357.
- Dziegielewska, K. M., et al. (1996) Histochem. Cell Biol. 106:319.
- Gangneux, C. et al. (2003) Nucleic Acids Res. 31:5957.
Alternate Names
FETUB
Entrez Gene IDs
26998 (Human)
Gene Symbol
FETUB
UniProt
Additional Fetuin B Products
Product Documents for Recombinant Human Fetuin B Protein, CF
Product Specific Notices for Recombinant Human Fetuin B Protein, CF
For research use only
Related Research Areas
Customer Reviews for Recombinant Human Fetuin B Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Fetuin B Protein, CF and earn rewards!
Have you used Recombinant Human Fetuin B Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human Fetuin B Protein, CF (1725-PI):
Materials
- Assay Buffer: 25 mM Sodium Acetate, 0.10 M NaCl, 5 mM DTT, pH 5.5
- Recombinant Human Fetuin B (rhFetuin B) (Catalog # 1725-PI)
- Recombinant Human Cathepsin V (rhCathepsin V) (Catalog # 1080-CY)
- Substrate: Z-Leu-Arg-AMC (Catalog # ES008)
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute rhCathepsin V to 2 µg/mL in Assay Buffer.
- Prepare a curve of rhFetuin B (MW: 41601 Da) in Assay Buffer. Make the following serial dilutions: 6000, 3000, 1500, 500, 250, 150, 100, 50, 25 and 2.5 nM.
- Mix equal volumes of the rhFetuin B curve dilutions and the diluted rhCathepsin V. Include a control (in duplicate) containing Assay Buffer and the diluted active rhCathepsin V.
- Incubate mixtures at room temperature for 30 minutes.
- Dilute Substrate to 20 µM in Assay Buffer.
- Load into a black well plate 50 µL of the incubated mixtures and start the reaction by adding 50 µL of 20 µM Substrate.
- Read at excitation and emission wavelengths of 380 nm and 460 nm (top read), respectively, in kinetic mode for 5 minutes.
- Derive the 50% inhibition concentration (IC50) for rhFetuin B by plotting RFU/min (or specific activity) vs. concentration with 4-PL fitting.
- The specific activity for rhCathepsin V at each point may be determined using the following formula (if needed):
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard 7-amino, 4-Methyl Coumarin (Sigma, Catalog # A-9891).
Per Well:
- rhCathepsin V: 0.050 µg
- rhFetuin B curve: 1500, 750, 375, 125, 62.5, 37.5, 25, 12.5, 6.25 and 0.625 nM
- Substrate: 10 µM